Pacific Biosciences of California, Inc. (PACB) Free cash flow 2016–2025
Pacific Biosciences of California, Inc. (PACB) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$113.9MFY2025 · since FY2016: -$76.1M → -$113.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$113.9M | +46.3% |
| FY2024 | -$212.2M | +20.8% |
| FY2023 | -$268.0M | +4.3% |
| FY2022 | -$280.0M | -139.1% |
| FY2021 | -$117.1M | -734.3% |
| FY2020 | $18.5M | +122.8% |
| FY2019 | -$81.1M | -18.8% |
| FY2018 | -$68.3M | +12.4% |
| FY2017 | -$78.0M | -2.4% |
| FY2016 | -$76.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice